(Q77309922)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9740537%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

review article

1 reference

title

Rational assessment of the interaction profile of cerivastatin supports its low propensity for drug interactions (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9740537%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

author name string

W Mück

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9740537%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

publication date

1 January 1998

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9740537%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9740537%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

volume

56 Suppl 1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9740537%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

page(s)

15-23; discussion 33

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9740537%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.2165/00003495-199856001-00003

4 December 2019

exact match

0 references

cites work

Interactions with hydroxymethylglutaryl-coenzyme A reductase inhibitors.

1 reference

12 December 2020

Accumulation of lovastatin, but not pravastatin, in the blood of cyclosporine-treated kidney graft patients after multiple doses

1 reference

12 December 2020

Influence of cholestyramine on the pharmacokinetics of cerivastatin.

1 reference

12 December 2020

Biotransformation of lovastatin. IV. Identification of cytochrome P450 3A proteins as the major enzymes responsible for the oxidative metabolism of lovastatin in rat and human liver microsomes

1 reference

12 December 2020

Pharmacodynamics and pharmacokinetics of the HMG-CoA reductase inhibitors. Similarities and differences

1 reference

12 December 2020

Macrolide antibacterials. Drug interactions of clinical significance

1 reference

12 December 2020

Influence of erythromycin pre- and co-treatment on single-dose pharmacokinetics of the HMG-CoA reductase inhibitor cerivastatin

1 reference

12 December 2020

Simvastatin but not pravastatin is very susceptible to interaction with the CYP3A4 inhibitor itraconazole.

1 reference

12 December 2020

Inter-ethnic comparisons of the pharmacokinetics of the HMG-CoA reductase inhibitor cerivastatin

1 reference

12 December 2020

In vitro metabolism of simvastatin in humans [SBT]identification of metabolizing enzymes and effect of the drug on hepatic P450s

1 reference

12 December 2020

Cerivastatin, a New Potent Synthetic HMG Co-A Reductase Inhibitor: Effect of 0.2 mg Daily in Subjects With Primary Hypercholesterolemia

1 reference

12 December 2020

Metabolism of cerivastatin by human liver microsomes in vitro. Characterization of primary metabolic pathways and of cytochrome P450 isozymes involved

1 reference

12 December 2020

Grapefruit juice greatly increases serum concentrations of lovastatin and lovastatin acid

1 reference

12 December 2020

LC separation and induced fluorometric detection of rivastatin in blood plasma

1 reference

12 December 2020

A medication database - a tool for detecting drug interactions in hospital

1 reference

12 December 2020

Influence of the antacid Maalox and the H2-antagonist cimetidine on the pharmacokinetics of cerivastatin.

1 reference

12 December 2020

Clinical pharmacokinetics of 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors

1 reference

12 December 2020

Extending therapy options in treating lipid disorders: a clinical review of cerivastatin, a novel HMG-CoA reductase inhibitor

1 reference

12 December 2020

Rhabdomyolysis associated with lovastatin and erythromycin use.

1 reference

12 December 2020

Cerivastatin: pharmacology of a novel synthetic and highly active HMG-CoA reductase inhibitor

1 reference

12 December 2020

Itraconazole drastically increases plasma concentrations of lovastatin and lovastatin acid

1 reference

12 December 2020

No pharmacokinetic or pharmacodynamic interaction between rivastatin and warfarin

1 reference

12 December 2020

Rhabdomyolysis from the coadministration of lovastatin and the antifungal agent itraconazole

1 reference

12 December 2020

Absolute and relative bioavailability of the HMG-CoA reductase inhibitor cerivastatin

1 reference

12 December 2020

Lack of pharmacokinetic interaction as an equivalence problem

1 reference

12 December 2020